Remifentanil vs Fentanyl in Children 7-12 After Urologic Surgery: Emergence Delirium and Recovery Quality

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age7-12
SponsorKonya City Hospital

About this trial

Emergence delirium (agitation) is a common complication in children recovering from general anesthesia, especially after sevoflurane. Affected children wake in a dissociative state - restless, crying, inconsolable, unaware of their surroundings - with a reported incidence of 25-80%. It raises the risk of self-injury, accidental catheter removal, vomiting, and maladaptive behavior persisting for weeks, and prolongs hospital stay.

Short-acting opioids such as fentanyl and remifentanil are widely used in pediatric anesthesia for sedation and analgesia and to blunt the hemodynamic response to surgical stimulation and airway instrumentation. Both have been proposed to reduce emergence agitation after sevoflurane anesthesia, but findings for remifentanil are inconsistent: some studies report a reduction, others an increase. Clinicians therefore lack clear guidance on opioid selection for maintenance.

This trial compares intraoperative remifentanil with intraoperative fentanyl maintenance on the occurrence of emergence delirium in children undergoing urologic surgery under general anesthesia. Secondary aims are postoperative recovery, duration of surgery, and intraoperative hemodynamics.

Design: single-center randomized controlled trial. 176 children aged 7-12 years, ASA I-II, scheduled for elective pediatric urologic surgery, randomized 1:1 (88 per group).

All participants receive the same background technique: intravenous midazolam 0.05 mg/kg five minutes before entering the operating room; standard monitoring (ECG, pulse oximetry, non-invasive blood pressure, capnography); induction with propofol 3-5 mg/kg; laryngeal mask airway (LMA); sevoflurane titrated to 1 MAC; and preemptive intravenous paracetamol and ketamine 0.3 mg/kg after induction.

The fentanyl group receives fentanyl 1 mcg/kg after loss of consciousness, then 1 mcg/kg every 30 minutes until the end of surgery. The remifentanil group receives remifentanil 0.5 mcg/kg, then an infusion of 1 mcg/kg/min. In both groups the LMA is inserted 90 seconds after the bolus.

At the end of surgery sevoflurane is discontinued and the LMA removed once the child breathes regularly and moves purposefully without stimulation. Emergence delirium is assessed in the post-anesthesia care unit with the Pediatric Anesthesia Emergence Delirium (PAED) scale (0-20). Additional measurements include time from sevoflurane discontinuation to LMA removal, time to eye opening on verbal stimulus, and readiness for discharge.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 7 to 12 years

American Society of Anesthesiologists (ASA) physical status I or II

Scheduled for elective pediatric urologic surgery

Surgery planned under general anesthesia with a laryngeal mask airway

Disqualifiers

History of difficult airway or known airway abnormality

Reactive airway disease

Respiratory tract infection within the preceding 3 weeks

Abnormal cognitive development or developmental delay

Trial design

Design model

Parallel

Treatments tested in this trial

  • Opioids

    Drug

    Remifentanil 0.5 microgram/kg intravenously after loss of consciousness, followed by a continuous maintenance infusion of 1 microgram/kg/minute until the end of surgery. And; Fentanyl 1 microgram/kg intravenously after loss of consciousness, followed by 1 microgram/kg intravenously every 30 minutes until the end of surgery.

Treatment groups

88 Participants
are divided into 2 treatment groups
Group A: Group R: RemifentanilActive comparator 1 intervention
Group B: Group F: FentanylActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of emergence delirium assessed by the Pediatric Anesthesia Emergence Delirium (PAED) scale

Emergence delirium is assessed in the post-anesthesia care unit using the Pediatric Anesthesia Emergence Delirium (PAED) scale by an assessor masked to group allocation. The scale comprises five items, each scored from 0 to 4, giving a total score from 0 to 20, where higher scores indicate more severe emergence delirium. A participant is classified as having emergence delirium if the peak PAED score is 10 or greater at any assessment. The outcome is reported as the proportion of participants in each arm meeting this threshold.

Time frame
From arrival in the post-anesthesia care unit until discharge criteria are met (modified Aldrete score greater than 9) plus 30 minutes of further observation, assessed up to 2 hours after discontinuation of sevoflurane

Secondary outcomes

1

Time to laryngeal mask airway removal

Interval from discontinuation of sevoflurane to removal of the laryngeal mask airway. The airway is removed when the child exhibits a regular respiratory pattern and purposeful movement of the extremities without physical stimulation. Recorded in minutes by a masked assessor.

Time frame
From discontinuation of sevoflurane to laryngeal mask airway removal, assessed up to 30 minutes
2

Time to eye opening

Interval from discontinuation of sevoflurane to eye opening in response to a verbal stimulus. Recorded in minutes by a masked assessor.

Time frame
From discontinuation of sevoflurane to eye opening, assessed up to 30 minutes
3

Time to post-anesthesia care unit discharge readiness

Interval from arrival in the post-anesthesia care unit to the point at which discharge criteria are met, defined as a modified Aldrete post-anesthesia score greater than 9. The modified Aldrete score assesses activity, respiration, circulation, consciousness and oxygen saturation, each scored 0 to 2, for a total of 0 to 10, with higher scores indicating more complete recovery. Recorded in minutes by a masked assessor.

Time frame
From arrival in the post-anesthesia care unit until a modified Aldrete score greater than 9 is achieved, assessed up to 2 hours
4

Incidence of intraoperative hypotension

Proportion of participants experiencing at least one episode of intraoperative hypotension, defined as a fall in mean arterial pressure of more than 20 percent below the pre-induction baseline value, sustained for at least one minute. Non-invasive blood pressure is measured at intervals of no more than 5 minutes throughout surgery.

Time frame
From induction of anesthesia to the end of surgery, assessed up to 4 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: